2013 Conditions Packaging Patients 
Cannabis Law Report
AUGUST 18, 2019
Ian Christensen was disbarred on January 18 after charging people nearly $800 for a “patient identification card” and other services, which he said would prevent his clients from being arrested for growing or having the drug on them, even before the state had legalized medical marijuana.
The Cannigma
OCTOBER 25, 2021
In 2018 Canada legalized recreational cannabis use, becoming the first G7 country to do so and only the second country after Uruguay, which legalized cannabis in 2013. Canadian law allows people to receive medical cannabis for any condition or symptoms approved by their personal healthcare practitioner.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
FEBRUARY 26, 2021
This is one of the reasons CBG is being researched for such an array of conditions. CBG’s interaction with certain receptors is currently being researched for conditions such as diabetes and obesity, and there are also indicators that suggest it could be researched for ADHD, PTSD and dementia. . Extraction type: Full spectrum.
Cannabis Law Report
JANUARY 9, 2019
Phoenix, headquartered in Denver, distributes medicinal cannabis products around the globe to treat seven major categories of medical conditions including pain, cancer, autoimmune, metabolic, neurological, psychological and sleep disorders. No doctor is going to say to a patient ‘smoke two joints and call me in the morning’,” he said.
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.
Cannabis Law Report
JANUARY 29, 2019
Cannabis should be classified as a medicinal product, she said, and therefore all active ingredients msu be displayed on the packaging. . “We Rather, pharmacies control the sale of regulated cannabis, and that resource must be poured into training and further education.
Cannabis Law Report
JULY 12, 2019
Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.
Expert insights. Personalized for you.
63 
Let's personalize your content